Chongqing Lummy Pharmaceutical (300006) — Financial Flexibility Index
Chongqing Lummy Pharmaceutical (300006) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥-4.17 Million (operating CF CN¥-14.90 Million minus capex CN¥10.73 Million) represents 0% of total liabilities (CN¥910.32 Million). Check Chongqing Lummy Pharmaceutical PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chongqing Lummy Pharmaceutical Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Chongqing Lummy Pharmaceutical across 19 annual periods. See Chongqing Lummy Pharmaceutical (300006) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Chongqing Lummy Pharmaceutical (2006–2024)
Year-by-year free cash flow to debt coverage for Chongqing Lummy Pharmaceutical. For the full company profile including market capitalisation, see Chongqing Lummy Pharmaceutical market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥260.54 Million | CN¥185.03 Million | CN¥972.47 Million | ▲ +46.2% |
| 2023 | 0.18x | CN¥140.85 Million | CN¥81.53 Million | CN¥768.71 Million | ▲ +27.2% |
| 2022 | 0.14x | CN¥125.32 Million | CN¥57.13 Million | CN¥870.02 Million | ▼ -29.9% |
| 2021 | 0.21x | CN¥146.94 Million | CN¥108.28 Million | CN¥714.65 Million | ▲ +46.9% |
| 2020 | 0.14x | CN¥268.12 Million | CN¥224.54 Million | CN¥1.92 Billion | ▼ -12.2% |
| 2019 | 0.16x | CN¥294.37 Million | CN¥231.30 Million | CN¥1.85 Billion | ▼ -35.8% |
| 2018 | 0.25x | CN¥351.82 Million | CN¥225.89 Million | CN¥1.42 Billion | ▲ +205.8% |
| 2017 | 0.08x | CN¥82.62 Million | CN¥61.39 Million | CN¥1.02 Billion | ▼ -67.5% |
| 2016 | 0.25x | CN¥202.63 Million | CN¥125.66 Million | CN¥809.85 Million | ▲ +1087.1% |
| 2015 | 0.02x | CN¥29.78 Million | CN¥-25.41 Million | CN¥1.41 Billion | ▼ -75.3% |
| 2014 | 0.09x | CN¥104.53 Million | CN¥-49.38 Million | CN¥1.23 Billion | ▼ -79.1% |
| 2013 | 0.41x | CN¥430.10 Million | CN¥74.70 Million | CN¥1.06 Billion | ▲ +48.5% |
| 2012 | 0.27x | CN¥195.51 Million | CN¥18.18 Million | CN¥713.21 Million | ▼ -21.5% |
| 2011 | 0.35x | CN¥146.95 Million | CN¥11.85 Million | CN¥420.81 Million | ▼ -17.6% |
| 2010 | 0.42x | CN¥136.63 Million | CN¥37.66 Million | CN¥322.42 Million | ▼ -2.9% |
| 2009 | 0.44x | CN¥56.09 Million | CN¥37.35 Million | CN¥128.55 Million | ▲ +34.7% |
| 2008 | 0.32x | CN¥42.35 Million | CN¥17.25 Million | CN¥130.77 Million | ▼ -13.8% |
| 2007 | 0.38x | CN¥40.12 Million | CN¥21.68 Million | CN¥106.78 Million | ▼ -2.1% |
| 2006 | 0.38x | CN¥23.30 Million | CN¥7.77 Million | CN¥60.72 Million | — |